All data are based on the daily closing price as of April 3, 2026
g
Grape King Bio
1707.TW
3.77 USD
-0.06
-1.57%
Overview
Last close
3.77 usd
Market cap
558.09M usd
52 week high
4.87 usd
52 week low
3.71 usd
Target price
4.32 usd
Valuation
P/E
14.7491
Forward P/E
17.3611
Price/Sales
1.7412
Price/Book Value
1.7547
Enterprise Value
440.41M usd
EV/Revenue
1.3739
EV/EBITDA
4.9263
Key financials
Revenue TTM
320.56M usd
Gross Profit TTM
240.68M usd
EBITDA TTM
81.23M usd
Earnings per Share
0.26 usd
Dividend
N/A usd
Total assets
501.40M usd
Net debt
-125.83M usd
About
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company provides health products and supplements; and microbial fermentation for mushroom mycelium, probiotics, and enzymes. It also offers functional ingredients for intestinal care, immunity regulation, liver care, brain health, eye care, weight control, feminine health, sensual health care, and others. It serves pharmaceutical preparations, finished drugs, oral liquids, and beverages and health foods. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.